## ## ||Page| |---|---| |Reference and administrative detailsofthe Company,itsTrustees andadvisers|1| |Trustees'report|2-5| |Independentauditors'reportonthe financial statements|6-9| |Consolidatedstatementoffinancialactivities|10| |Consolidated balancesheet|11- 12| |Companybalance sheet|13-14| |Consolidated statementofcashflows|15| |Notestothefinancial statements|16 - 34| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||Unrestricted|Restricted|Total|_Total_| |---|---|---|---|---|---| |||funds|funds|funds|_funds_| |||2021|2021|2021|_2020_| ||Note|£|£|£|£| |Incomefrom:|||||| |Donations and legacies|3|520|1,000|1,520|_14,701_| |Other trading activities|4|1,177,061||1,177,061|_987, 168_| |Investments|5||119|119|_868_| |Other income|6|73,596||73,596|_13,000_| |Total income||1,251,177|1,119|1,252,296|_1,015,737_| |Expenditureon:|||||| |Raising funds|7|917,037||917,037|_1,132,548_| |Charitable activities|8|6,420|500|6,920|_11,350_| |Total expenditure||923,457|500|923,957|_1,143,898_| |Netmovementinfunds||327,720|619|328,339|_(128, 161)_| |Reconciliationoffunds:|||||| |Total funds brought forward||3,583,143|62,989|3,646,132|_3,774,293_| |Net movementinfunds||327,720|619|328,339|_(128, 161)_| |Totalfundscarriedforward||3,910,863|63,608|3,974,471|_3,646, 132_| ## ## ||||2021||_2020_| |---|---|---|---|---|---| ||Note||£||£| |Fixed assets|||||| |Tangible assets|13||3,464,822||_3,578,283_| ||||3,464,822||_3,578,283_| |Currentassets|||||| |Stocks|15|8,847||_7,369_|| |Debtors|16|25,604||_334,225_|| |Cash at bank andinhand||573,004||_116,033_|| |||607,455||_457,627_|| |Creditors: amounts falling due within one|||||| |year|17|(97,805)||_(379,777)_|| |Netcurrentassets|||509,650||_77,850_| |Total assets lesscurrentliabilities|||3,974,472||_3,656, 133_| |Creditors: amounts falling due after more|||||| |than one year|18||(1)||_(10,001)_| |Totalnetassets|||3,974,471||_3,646, 132_| |Charityfunds|||||| |Restricted funds|19||63,608||_62,989_| |Unrestricted funds|19||3,910,863||_3,583, 143_| |Totalfunds|||3,974,471||_3,646, 132_| ## ## ## ## ## ||||2021||_2020_| |---|---|---|---|---|---| ||Note||£||£| |Fixed assets|||||| |Tangible assets|13||12,870||_12,870_| |Investments|14||3,840,149||_3,490,508_| ||||3,853,019||_3,503,378_| |Currentassets|||||| |Debtors|16|45,799||_48,745_|| |Cash at bank andinhand||82,529||_113,403_|| |||128,328||_162, 148_|| |Creditors: amounts falling due within one|||||| |year|17|(6,875)||_(19,396)_|| |Netcurrentassets|||121,453||_142,752_| |Totalnetassets|||3,974,472||_3,646, 130_| |Charityfunds|||||| |Restricted funds|19||63,608||_62,989_| |Unrestricted funds|19||3,910,864||_3,583, 141_| |Totalfunds|||3,974,472||_3,646, 130_| # # ## ## ||2021|_2020_| |---|---|---| ||£|£| |Cashflowsfromoperating activities||| |Net cash used in operating activities|488,079|_(18,983)_| |Cashflowsfrominvesting activities||| |Interest receivable|(119)|_(868)_| |Purchaseoftangible fixed assets|(5,814)|_(81,807)_| |Net cash used in investing activities|(5,933)|(82,675)| |Cashflowsfromfinancing activities||| |Net cashprovidedbyfinancingactivities||| |Changeincash and cash equivalents in the year|482,146|(101,658)| |Cash and cash equivalents at the beginning of the year|90,858|_192,516_| |Cash and cash equivalents at the endofthe year|573,004|_90,858_| |The notes on pages 16 to 34 form partofthese financial statements||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||**Unrestricted**|**Restricted**|**Total**|_Total_| |---|---|---|---|---| ||**funds**|**funds**|**funds**|_funds_| ||**2021**|**2021**|**2021**|_2020_| ||£|£|£|£| |Donations|520||**520**|_11,701_| |Grants||1,000|**1,000**|_3,000_| ||520|1,000|**1,520**|_14,701_| |_Total 2020_|_11,701_|_3,000_|_14,701_|| ## ## ## ## ||Unrestricted|Total|_Total_| |---|---|---|---| ||funds|funds|_funds_| ||2021|2021|_2020_| ||£|£|£| |Charity trading income|1,177,061|1,177,061|_987, 168_| |_Total 2020_|_987, 168_|_987, 168_|| ## ||Unrestricted|Restricted|Total|_Total_| |---|---|---|---|---| ||funds|funds|funds|_funds_| ||2021|2021|2021|_2020_| ||£|£|£|£| |Interest received||119|119|_868_| |_Total 2020_|_852_|_16_|_868_|| ## ||Unrestricted|Total|_Total_| |---|---|---|---| ||funds|funds|_funds_| ||2021|2021|_2020_| ||£|£|£| |Government grants receivable|60,596|60,596|| |Other income|13,000|13,000|_13,000_| ||73,596|73,596|_13,000_| |_Total 2020_|_13,000_|_13,000_|| ## ## ## ## ## ||Unrestricted|Total|_Total_| |---|---|---|---| ||funds|funds|_funds_| ||2021|2021|_2020_| ||£|£|£| |Costsofraising funds|349|349|_5,329_| |_Total 2020_|_5,329_|_5,329_|| |Fundraisingtradingexpenses|||| ||Unrestricted|Total|_Total_| ||funds|funds|_funds_| ||2021|2021|_2020_| ||£|£|£| |Costofsales and administrative expenses|797,413|797,413|_999,547_| |Depreciation|119,275|119,275|_127,672_| ||916,688|916,688|_1,127,219_| |_Total 2020_|_1,127,219_|_1,127,219_|| ## ## ## ## ## ||||Unrestricted|Restricted|Total|_Total_| |---|---|---|---|---|---|---| ||||funds|funds|funds|_funds_| ||||2021|2021|2021|_2020_| ||||£|£|£|£| |General fund|||6,420||6,420|_8,350_| |Basingstoke Breast Cancer self|help group|||500|500|_3,000_| ||||6,420|500|6,920|_11,350_| |_Total 2020_|||_8,350_|_3,000_|_11,350_|| |Analysisofexpenditure by activities||||||| |||Activities|Grant|||| ||undertaken||fundingof|Support|Total|_Total_| |||directly|
activities|costs|funds|_funds_| |||2021|2021|2021|2021|_2020_| |||£|£|£|£|£| |General fund||||6,420|6,420|_8,,350_| |Basingstoke Breast Cancer self||||||| |help group|||500||500|_3,000_| ||||500|6,420|6,920|_11,350_| |_Total 2020_||_3,230_|_1,500_|_6,620_|_11,350_|| ## ## ## ## ## |**Auditors' remuneration**||| |---|---|---| ||**2021**|_2020_| ||£|£| |Fees payable to the Company's auditor for the auditofthe Company's||| |annual accounts|**5,546**|_5,705_| |Fees payable to the Company's auditor in respect of:||| |Audit of the subsidiary annual accounts|**5,530**|_5,625_| |All non-audit services not included above|**648**|_600_| ## ||**Group**|_Group_| |---|---|---| ||**2021**|_2020_| ||**No.**|_No._| |Employees|**16**|_21_| ||**Group**|_Group_| |---|---|---| ||**2021**|_2020_| ||**No.**|_No._| |Inthe band £70,001 - £80,000|**1**|_1_| |The Company had 0 employees (2020 - 0).||| ## ## |||NOTES TO THE FINANCIAL STATEMENTS||| |---|---|---|---|---| |||FOR THE YEAR ENDED31MARCH2021||| |13.|Tangible fixed assets|||| ||Group|||| |||Long-term|Plant,|| |||leasehold|machinery&|| |||property|fixtures|Total| |||£|£|£| ||Costorvaluation|||| ||At 1 April 2020|4,403,885|1,568,064|5,971,949| ||Additions||5,814|5,814| ||At31March2021|4,403,885|1,573,878|5,977,763| ||Depreciation|||| ||At 1 April 2020|1,133,631|1,260,035|2,393,666| ||Charge for the year|37,279|81,996|119,275| ||At31March2021|1,170,910|1,342,031|2,512,941| ||Netbookvalue|||| ||At31March2021|3,232,975|231,847|3,464,822| ||_At31March 2020_|_3,270,254_|_308,029_|_3,578,283_| ## ## ## ## ||Fixtures,| |---|---| ||fittings&| ||equipment| ||£| |Costorvaluation|| |At 1 April 2020|13,350| |At31March2021|13,350| |Depreciation|| |At 1 April 2020|480| |At31March2021|480| |Netbookvalue|| |At31March2021|12,870| |_At31March 2020_|_12,870_| ## ## ## ## ## ||Investments| |---|---| ||in| ||subsidiary| ||companies| |Company|£| |Costorvaluation|| |At 1 April 2020|5,707,042| |Additions|26,927| |At31March2021|5,733,969| |Impairment|| |At 1 April 2020|2,216,534| |Reversalofimpairment|(322,714)| |At31March2021|1,893,820| |Netbookvalue|| |At31March2021|3,840,149| |_At31March 2020_|_3,490,508_| ## ## ## ## |Name|||Company|Registered officeorprincipal|Principalactivity| |---|---|---|---|---|---| ||||number|placeofbusiness|| |The Ark Conference Centre|||03683701|Dinwoodie Drive, Basingstoke,|Provisionofa facility| |Limited||||Hampshire, RG24 9NN|for conferencing and| ||||||traininginthe fieldof| ||||||medicine| |Classof|Holding|Included|in||| |shares||consolidation|||| |Ordinary|100%|Yes|||| ||The financial results of the subsidiary for|the year were:||||| |---|---|---|---|---|---|---| ||Name|Income|Expenditure|Profitfor||Net assets| |||£|£|theyear||£| ||||||£|| ||The Ark Conference Centre Limited|1,239,402|(916,688)|322,714||3,840,150| |15.|Stocks|||||| ||||||Group|_Group_| ||||||2021|_2020_| ||||||£|£| ||Finished goods and goods for resale||||8,847|_7,369_| ## ## ## ## ||**Group**|_Group_|**Company**|_Company_| |---|---|---|---|---| ||**2021**|_2020_|**2021**|_2020_| ||£|£|£|£| |Trade debtors|**5,944**|_313, 147_||| |Other debtors|**3,809**|||| |Prepayments and accrued income|**15,851**|_21,078_|**45,799**|_48,745_| ||**25,604**|_334,225_|**45,799**|_48,745_| ## ||**Group**|_Group_|**Company**|_Company_| |---|---|---|---|---| ||**2021**|_2020_|**2021**|_2020_| ||£|£|£|£| |Bank overdrafts||_25, 175_||| |Trade creditors|**23,099**|_40,352_||| |Other taxation and social security|**9,145**|_75,959_||| |Other creditors|**1,490**|_1,790_||| |Accruals and deferred income|**64,071**|_236,501_|**6,875**|_19,396_| ||**97,805**|379,777|**6,875**|_19,396_| ## ## ## ||**Group**|_Group_|_Company_| |---|---|---|---| ||**2021**|_2020_|_2020_| ||£|£|£| |Other loans|**1**|_1_|| |Accruals and deferred income||_10,000_|| ||**1**|_10,001_|| ## ## ## |Statementoffunds-currentyear||||| |---|---|---|---|---| |||||Balanceat| ||Balanceat1|||31March| ||April2020|Income|Expenditure|2021| ||£|£|£|£| |Unrestrictedfunds||||| |Reserves|3,583,143|1,251,177|(923,457)|3,910,863| |Restrictedfunds||||| |Training fund|62,989|119||63,108| |Basingstoke Breast Cancer self-help group||1,000|(500)|500| ||62,989|1,119|(500)|63,608| |Totaloffunds|3,646,132|1,252,296|(923,957)|3,974,471| ## ## ## ## ## |Summaryoffunds-prioryear||||| |---|---|---|---|---| |||||_Balance at_| ||_Balance at_|||_31March_| ||_1April2019_|_Income_|_Expenditure_|_2020_| ||£|£|£|£| |General funds|_3,711,320_|_1,012,721_|_(1,140,898)_|_3,583,143_| |Restricted funds|_62,973_|_3,016_|_(3,000)_|_62,989_| ||_3,774,293_|_1,015, 737_|_(1,143,898)_|_3,646, 132_| ## ||Unrestricted|Restricted|Total| |---|---|---|---| ||funds|funds|funds| ||2021|2021|2021| ||£|£|£| |Tangible fixed assets|3,464,822||3,464,822| |Current assets|543,347|64,108|607,455| |Creditors due within one year|(97,305)|(500)|(97,805)| |Creditors dueinmore than one year|(1)||(1)| |Total|3,910,863|63,608|3,974,471| ## ## ## ||_Unrestricted_|_Restricted_|_Total_| |---|---|---|---| ||_cfunds_|_funds_|_funds_| ||_2020_|_2020_|_2020_| ||£|£|£| |Tangible fixed assets|3,578,283||_3,578,283_| |Current assets|394,638|62,989|_457,627_| |Creditors due within one year|(379,777)||_(379,777)_| |Creditors due in more than one year|(10,001)||_(10,001)_| ||3,583,143|62,989|_3,646, 132_| ## ## ||Group|_Group_| |---|---|---| ||2021|_2020_| ||£|£| |Net income/expenditure for the year (as per StatementofFinancial||| |Activities)|328,339|_(128, 161)_| |Adjustmentsfor:||| |Depreciation charges|119,275|_127,672_| |Interest receivable|119|_868_| |Lossonthe saleoffixed assets||_154_| |Decrease/(increase)instocks|(1,478)|_2,028_| |Decrease/(increase)indebtors|308,621|_(35,015)_| |lncrease/(decrease)increditors|(266,797)|_13,471_| |Net cash provided by/(used in) operatingactivities|488,079|_(18,983)_| ## ## ## ||Group|_Group_| |---|---|---| ||2021|_2020_| ||£|£| |Cashinhand|573,004|_116,033_| |Overdraft facility repayable on demand||_(25, 175)_| |Total cash and cash equivalents|573,004|_90,858_| ## ||At1April||At31March| |---|---|---|---| ||2020|Cashflows|2021| |||£|£| ||£||| |Cash at bank and in hand|116,033|456,971|573,004| |Bank overdrafts repayable on demand|(25, 175)|25,175|| |Debt due after 1 year|(1)||(1)| ||90,857|482,146|573,003| ## **Document Activity Report** ## **Document Sent** Thu, 13 Jan 2022 15:00:47 GMT ## **Document Activity History** Document history shows most recent activity first ## **Date** ## **Activity** You can verify that this is a genuine Portal document by uploading it to the following secure web page: **https://wiseandco.accountantspace.co.uk/messages/VerifyDocument**